Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 10
2004 5
2005 13
2006 11
2007 14
2008 6
2009 2
2010 4
2011 5
2012 11
2013 11
2014 5
2015 6
2016 6
2017 5
2018 2
2019 5
2020 12
2021 6
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Results by year

Filters applied: . Clear all
Page 1
Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial.
Trimble CL, Morrow MP, Kraynyak KA, Shen X, Dallas M, Yan J, Edwards L, Parker RL, Denny L, Giffear M, Brown AS, Marcozzi-Pierce K, Shah D, Slager AM, Sylvester AJ, Khan A, Broderick KE, Juba RJ, Herring TA, Boyer J, Lee J, Sardesai NY, Weiner DB, Bagarazzi ML. Trimble CL, et al. Among authors: boyer j. Lancet. 2015 Nov 21;386(10008):2078-2088. doi: 10.1016/S0140-6736(15)00239-1. Epub 2015 Sep 17. Lancet. 2015. PMID: 26386540 Free PMC article. Clinical Trial.
Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.
Aggarwal C, Saba NF, Algazi A, Sukari A, Seiwert TY, Haigentz M, Porosnicu M, Bonomi M, Boyer J, Esser MT, Cheng LI, Agrawal S, Jennings EC, Durham NM, Fraser K, Lissa D, Gong M, Ceaicovscaia N, Gascó Hernández A, Kumar R. Aggarwal C, et al. Among authors: boyer j. Clin Cancer Res. 2023 Feb 1;29(3):560-570. doi: 10.1158/1078-0432.CCR-22-1987. Clin Cancer Res. 2023. PMID: 36455147 Free PMC article.
Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection.
Jacobson JM, Zahrieh D, Strand CA, Cruz-Correa M, Pungpapong S, Roberts LR, Mandrekar SJ, Rodriguez LM, Boyer J, Marrero I, Kraynyak KA, Morrow MP, Sylvester AJ, Pawlicki JM, Gillespie E, Barranco E, Richmond E, Umar A, Weiner DB, Limburg PJ; Cancer Prevention Network. Jacobson JM, et al. Among authors: boyer j. Cancer Prev Res (Phila). 2023 Mar 1;16(3):163-173. doi: 10.1158/1940-6207.CAPR-22-0217. Cancer Prev Res (Phila). 2023. PMID: 36534786 Free PMC article. Clinical Trial.
Prise en charge de l'hémorragie d'origine diverticulaire.
Pilleul F, Buc E, Dupas JL, Boyer J, Bruel JM, Berdah S. Pilleul F, et al. Among authors: boyer j. Gastroenterol Clin Biol. 2007 Sep;31(8-9P2):47-52. doi: 10.1016/S0399-8320(07)91951-X. Epub 2007 Oct 30. Gastroenterol Clin Biol. 2007. PMID: 24928749 Free article. French. No abstract available.
Traitement médical des diverticulites aiguës non compliquées.
Bourreille A, Montravers P, Boyer J, Schmit JL, Teillet L, Loiseau D. Bourreille A, et al. Among authors: boyer j. Gastroenterol Clin Biol. 2007 Sep;31(8-9P2):21-6. doi: 10.1016/S0399-8320(07)91948-X. Epub 2007 Oct 30. Gastroenterol Clin Biol. 2007. PMID: 24928746 Free article. French. No abstract available.
HIV-1 vaccines and co-infection.
Robinson TM, Boyer JD. Robinson TM, et al. Among authors: boyer jd. Expert Opin Biol Ther. 2004 Sep;4(9):1483-92. doi: 10.1517/14712598.4.9.1483. Expert Opin Biol Ther. 2004. PMID: 15335315 Review.
Therapeutic and prophylactic DNA vaccines for HIV-1.
Ramirez LA, Arango T, Boyer J. Ramirez LA, et al. Among authors: boyer j. Expert Opin Biol Ther. 2013 Apr;13(4):563-73. doi: 10.1517/14712598.2013.758709. Expert Opin Biol Ther. 2013. PMID: 23477730 Review.
Immunogenicity of a DNA vaccine candidate for COVID-19.
Smith TRF, Patel A, Ramos S, Elwood D, Zhu X, Yan J, Gary EN, Walker SN, Schultheis K, Purwar M, Xu Z, Walters J, Bhojnagarwala P, Yang M, Chokkalingam N, Pezzoli P, Parzych E, Reuschel EL, Doan A, Tursi N, Vasquez M, Choi J, Tello-Ruiz E, Maricic I, Bah MA, Wu Y, Amante D, Park DH, Dia Y, Ali AR, Zaidi FI, Generotti A, Kim KY, Herring TA, Reeder S, Andrade VM, Buttigieg K, Zhao G, Wu JM, Li D, Bao L, Liu J, Deng W, Qin C, Brown AS, Khoshnejad M, Wang N, Chu J, Wrapp D, McLellan JS, Muthumani K, Wang B, Carroll MW, Kim JJ, Boyer J, Kulp DW, Humeau LMPF, Weiner DB, Broderick KE. Smith TRF, et al. Among authors: boyer j. Nat Commun. 2020 May 20;11(1):2601. doi: 10.1038/s41467-020-16505-0. Nat Commun. 2020. PMID: 32433465 Free PMC article.
126 results